JP2014508734A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014508734A5 JP2014508734A5 JP2013546764A JP2013546764A JP2014508734A5 JP 2014508734 A5 JP2014508734 A5 JP 2014508734A5 JP 2013546764 A JP2013546764 A JP 2013546764A JP 2013546764 A JP2013546764 A JP 2013546764A JP 2014508734 A5 JP2014508734 A5 JP 2014508734A5
- Authority
- JP
- Japan
- Prior art keywords
- fluorocarbon
- peptide
- linked
- formulation
- acid residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1022147.1 | 2010-12-31 | ||
| GB201022147A GB201022147D0 (en) | 2010-12-31 | 2010-12-31 | Formulation |
| PCT/GB2011/001781 WO2012090002A1 (en) | 2010-12-31 | 2011-12-30 | Fluorocarbon-linked peptide formulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016153693A Division JP6279672B2 (ja) | 2010-12-31 | 2016-08-04 | フルオロカーボン連結ペプチド製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014508734A JP2014508734A (ja) | 2014-04-10 |
| JP2014508734A5 true JP2014508734A5 (OSRAM) | 2015-02-26 |
| JP6054302B2 JP6054302B2 (ja) | 2016-12-27 |
Family
ID=43638974
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013546764A Expired - Fee Related JP6054302B2 (ja) | 2010-12-31 | 2011-12-30 | フルオロカーボン連結ペプチド製剤 |
| JP2016153693A Expired - Fee Related JP6279672B2 (ja) | 2010-12-31 | 2016-08-04 | フルオロカーボン連結ペプチド製剤 |
| JP2018005604A Active JP6514373B2 (ja) | 2010-12-31 | 2018-01-17 | フルオロカーボン連結ペプチド製剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016153693A Expired - Fee Related JP6279672B2 (ja) | 2010-12-31 | 2016-08-04 | フルオロカーボン連結ペプチド製剤 |
| JP2018005604A Active JP6514373B2 (ja) | 2010-12-31 | 2018-01-17 | フルオロカーボン連結ペプチド製剤 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US9119811B2 (OSRAM) |
| EP (1) | EP2658572B1 (OSRAM) |
| JP (3) | JP6054302B2 (OSRAM) |
| KR (6) | KR102430298B1 (OSRAM) |
| CN (2) | CN103429259A (OSRAM) |
| AU (1) | AU2011350997B2 (OSRAM) |
| BR (1) | BR112013016870A2 (OSRAM) |
| CA (1) | CA2823453C (OSRAM) |
| CL (1) | CL2013001935A1 (OSRAM) |
| DK (1) | DK2658572T3 (OSRAM) |
| EA (1) | EA028396B1 (OSRAM) |
| ES (1) | ES2645017T3 (OSRAM) |
| GB (2) | GB201022147D0 (OSRAM) |
| IL (1) | IL227273A0 (OSRAM) |
| MX (1) | MX348954B (OSRAM) |
| WO (1) | WO2012090002A1 (OSRAM) |
| ZA (1) | ZA201305591B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0408164D0 (en) | 2004-04-13 | 2004-05-19 | Immune Targeting Systems Ltd | Antigen delivery vectors and constructs |
| GB0716992D0 (en) | 2007-08-31 | 2007-10-10 | Immune Targeting Systems Its L | Influenza antigen delivery vectors and constructs |
| GB201022147D0 (en) | 2010-12-31 | 2011-02-16 | Immune Targeting Systems Its Ltd | Formulation |
| GB201223386D0 (en) | 2012-12-24 | 2013-02-06 | Immune Targeting Systems Its Ltd | Vaccine |
| GB201315946D0 (en) * | 2013-09-06 | 2013-10-23 | Immune Targeting Systems Its Ltd | Oncology vaccine |
| GB201321242D0 (en) | 2013-12-02 | 2014-01-15 | Immune Targeting Systems Its Ltd | Immunogenic compound |
| TW202241500A (zh) * | 2015-06-09 | 2022-11-01 | 美商博德研究所有限公司 | 用於贅瘤疫苗之調配物及其製備方法 |
| KR20240149976A (ko) | 2017-04-04 | 2024-10-15 | 바린투스 바이오테라퓨틱스 노쓰 아메리카, 인크. | 펩티드-기반 백신, 그의 제조 방법, 및 면역 반응을 유도하기 위한 그의 용도 |
| CN118384268A (zh) | 2017-04-18 | 2024-07-26 | 阿尔尼拉姆医药品有限公司 | 具有乙肝病毒（hbv）感染的受试者的治疗方法 |
| CN112423787A (zh) * | 2018-07-10 | 2021-02-26 | 思齐乐私人有限公司 | 团聚物的去除 |
| WO2022015662A1 (en) * | 2020-07-12 | 2022-01-20 | Altimmune, Inc | Coronavirus immunogenic t cell epitope compositions and uses thereof |
| WO2024186890A1 (en) | 2023-03-06 | 2024-09-12 | Intellia Therapeutics, Inc. | Compositions and methods for hepatitis b virus (hbv) genome editing |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5055562A (en) | 1988-02-01 | 1991-10-08 | Biomira, Inc. | Fluorocarbon chain-containing antigenic conjugates |
| US6828415B2 (en) | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
| DE4305225A1 (de) * | 1993-02-19 | 1994-08-25 | Asta Medica Ag | Neues Herstellverfahren für Cetrorelix Lyophilisat |
| FR2771640B1 (fr) * | 1997-12-03 | 2000-02-11 | Inst Nat Sante Rech Med | Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques |
| ATE381945T1 (de) * | 2004-03-12 | 2008-01-15 | Intercell Ag | Verfahren zur solubilisierung von peptid- mischungen |
| GB0408164D0 (en) | 2004-04-13 | 2004-05-19 | Immune Targeting Systems Ltd | Antigen delivery vectors and constructs |
| GB0716992D0 (en) * | 2007-08-31 | 2007-10-10 | Immune Targeting Systems Its L | Influenza antigen delivery vectors and constructs |
| GB201022147D0 (en) | 2010-12-31 | 2011-02-16 | Immune Targeting Systems Its Ltd | Formulation |
| GB201223386D0 (en) * | 2012-12-24 | 2013-02-06 | Immune Targeting Systems Its Ltd | Vaccine |
-
2010
- 2010-12-31 GB GB201022147A patent/GB201022147D0/en not_active Ceased
-
2011
- 2011-12-30 KR KR1020227002651A patent/KR102430298B1/ko active Active
- 2011-12-30 CN CN2011800678387A patent/CN103429259A/zh active Pending
- 2011-12-30 KR KR1020207011186A patent/KR102219009B1/ko not_active Expired - Fee Related
- 2011-12-30 EP EP11807967.2A patent/EP2658572B1/en active Active
- 2011-12-30 MX MX2013007635A patent/MX348954B/es active IP Right Grant
- 2011-12-30 DK DK11807967.2T patent/DK2658572T3/en active
- 2011-12-30 WO PCT/GB2011/001781 patent/WO2012090002A1/en not_active Ceased
- 2011-12-30 AU AU2011350997A patent/AU2011350997B2/en not_active Ceased
- 2011-12-30 JP JP2013546764A patent/JP6054302B2/ja not_active Expired - Fee Related
- 2011-12-30 KR KR1020197024473A patent/KR102103920B1/ko active Active
- 2011-12-30 KR KR1020137020378A patent/KR101905749B1/ko not_active Expired - Fee Related
- 2011-12-30 BR BR112013016870A patent/BR112013016870A2/pt not_active Application Discontinuation
- 2011-12-30 GB GB201313381A patent/GB2502716A/en not_active Withdrawn
- 2011-12-30 CN CN201510511728.5A patent/CN105148265B/zh not_active Expired - Fee Related
- 2011-12-30 KR KR1020217004652A patent/KR102356875B1/ko not_active Expired - Fee Related
- 2011-12-30 KR KR1020187028311A patent/KR102014919B1/ko not_active Expired - Fee Related
- 2011-12-30 EA EA201390998A patent/EA028396B1/ru not_active IP Right Cessation
- 2011-12-30 ES ES11807967.2T patent/ES2645017T3/es active Active
- 2011-12-30 CA CA2823453A patent/CA2823453C/en active Active
- 2011-12-30 US US13/977,265 patent/US9119811B2/en active Active
-
2013
- 2013-06-28 CL CL2013001935A patent/CL2013001935A1/es unknown
- 2013-06-30 IL IL227273A patent/IL227273A0/en unknown
- 2013-07-23 ZA ZA2013/05591A patent/ZA201305591B/en unknown
-
2015
- 2015-07-23 US US14/807,606 patent/US10729759B2/en active Active
-
2016
- 2016-08-04 JP JP2016153693A patent/JP6279672B2/ja not_active Expired - Fee Related
-
2018
- 2018-01-17 JP JP2018005604A patent/JP6514373B2/ja active Active
-
2020
- 2020-06-23 US US16/909,040 patent/US11648305B2/en active Active
-
2023
- 2023-04-12 US US18/133,767 patent/US20240042007A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014508734A5 (OSRAM) | ||
| Luo et al. | A powerful CD8+ T-cell stimulating D-tetra-peptide hydrogel as a very promising vaccine adjuvant | |
| Sokolova et al. | The potential of nanoparticles for the immunization against viral infections | |
| JP2010500399A5 (OSRAM) | ||
| Bailey et al. | Self-encapsulating poly (lactic-co-glycolic acid)(PLGA) microspheres for intranasal vaccine delivery | |
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| RU2010114033A (ru) | Применение ингибитора nf-каппа в sn50 и необязательно ангиотензина iii в качестве терапевтических средств при лечении, например, инфекции hbv | |
| JP2008530245A5 (OSRAM) | ||
| CN107412943A (zh) | 一种可溶性微针贴片及其制备方法 | |
| JP2018521028A5 (OSRAM) | ||
| JP2012506411A5 (OSRAM) | ||
| EP3600396A1 (en) | Nucleic acid vaccine composition comprising a lipid formulation, and method of increasing the potency of nucleic acid vaccines | |
| Nguyen et al. | Skin immunization with third-generation hepatitis B surface antigen using microneedles | |
| Xu et al. | Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection | |
| JP2023138946A (ja) | 呼吸器合胞体ウイルスに対する予防のための環状ペプチド | |
| JP5766894B2 (ja) | ワクチン増強剤としてのαチモシンペプチド | |
| KR101751376B1 (ko) | 점막 백신 | |
| CN113491766A (zh) | 恢复对抗癌症的nkg2d通路功能的疫苗组合物和方法 | |
| Zhang et al. | Silk Fibroin-Coated Nano-MOFs Enhance the Thermal Stability and Immunogenicity of HBsAg | |
| JP2019534242A5 (OSRAM) | ||
| JP2020515283A5 (OSRAM) | ||
| JP2011524372A (ja) | インフルエンザワクチン接種のための新規ペプチドアジュバント | |
| CN107200788A (zh) | 一种季鏻化壳聚糖及其作为疫苗免疫佐剂的应用 | |
| ES2363616T3 (es) | Composiciones farmacéuticas que contienen anticuerpo monoclonal antidiotípico anti-ca125 y aluminio. | |
| JP4724000B2 (ja) | ポリペプチド |